本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BIONDVAX PHARMACEUTICALS SPON ADS EACH REP 400 ORD SHS(POST SPLT)

1.36
0.0000
成交量:- -
成交额:3.03万
市值:496.66万
市盈率:-0.44
高:1.36
开:1.36
低:1.36
收:1.36
数据加载中...
2020/06/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/13

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/03/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/24

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]